DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zemuron (Rocuronium Bromide) - Published Studies


Zemuron Related Published Studies

Well-designed clinical trials related to Zemuron (Rocuronium)

Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial. [2011.08.16]

A comparative study between 1 and 2 effective doses of rocuronium for intraoperative neuromonitoring during thyroid surgery. [2011.04]

A randomized trial to identify optimal precurarizing dose of rocuronium to avoid precurarization-induced neuromuscular block. [2011.04]

The effect of low dose rocuronium on intraocular pressure in laryngeal mask airway usage. [2011.02]

Desaturation following rapid sequence induction using succinylcholine vs. rocuronium in overweight patients. [2011.02]

A short period of inhalation induction with sevoflurane prevents rocuronium-induced withdrawal in children. [2011.01]

Rocuronium for nonemergent intubation of term and preterm infants. [2011.01]

Local warming at injection site helps alleviate pain after rocuronium administration. [2010.12]

Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship. [2010.11]

Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial. [2010.10]

A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex. [2010.10]

The analgesic effect of remifentanil on prevention of withdrawal response associated with the injection of rocuronium in children: no evidence for a peripheral action. [2010.09]

Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function. [2010.09]

Potency and recovery characteristics of rocuronium mixed with sodium bicarbonate. [2010.09]

Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium. [2010.08]

[Tracheal intubation quality under remifentanil-propofol with sevoflurane compared with remifentanil-propofol with rocuronium: a randomized double-blind clinical trial] [2010.06]

Rocuronium profile during orthotopic liver transplantation: effect of changing the order of vascular clamp release at reperfusion of the hepatic graft. [2010.06]

Effect of suxamethonium vs rocuronium on onset of oxygen desaturation during apnoea following rapid sequence induction. [2010.04]

Effectiveness of the timing principle with high-dose rocuronium during rapid sequence induction with lidocaine, remifentanil and propofol. [2010.04]

Time course of rocuronium-induced neuromuscular block after pre-treatment with magnesium sulphate: a randomised study. [2010.03]

[Optimum intubating dose of rocuronium for short duration surgery in adult patients] [2010.02]

Ketamine, but not priming, improves intubating conditions during a propofol-rocuronium induction. [2010.02]

A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. [2010.01.01]

Reduced-dose rocuronium for day-case tonsillectomy in children where volatile anaesthetics are not used: operating room time saving. [2010.01]

Effect of the addition of rocuronium to local anesthetics for peribulbar block. [2010]

Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. [2010]

To asses the effects of rocuronium pretreatment on succinylcholine induced fasciculations and postoperative myalgias. [2009.12]

[Influence of gender on the potency and course of action of rocuronium bromide] [2009.12]

Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis muscles. [2009.11]

Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery. [2009.10]

Antihistamine pretreatment to reduce incidence of withdrawal movement after rocuronium injection. [2009.10]

Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term. [2009.09]

Should dosing of rocuronium in obese patients be based on ideal or corrected body weight? [2009.09]

Rapid injection of rocuronium reduces withdrawal movement on injection. [2009.09]

Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. [2009.07]

Excellent intubating conditions with remifentanil-propofol and either low-dose rocuronium or succinylcholine. [2009.07]

[Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia] [2009.06]

Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. [2009.05]

Rocuronium dose-dependently suppresses the spectral entropy response to tracheal intubation during propofol anaesthesia. [2009.05]

[Rocuronium vs atracurium vs suxamethonium for double-lumen endobronchial tube intubation] [2009.04]

[A comparison of the effect of lidocaine or sodium bicarbonate mixed with rocuronium on withdrawal movement, mean arterial pressure and heart rate during rocuronium injection] [2009.04]

Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia. [2009.02]

Alfentanil is comparable to remifentanil in preventing withdrawal movement following rocuronium injection. [2009.02]

Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. [2009.02]

[Evaluation of tracheal intubation conditions in morbidly obese patients: a comparison of succinylcholine and rocuronium] [2009.01]

Priming with rocuronium to accelerate the onset time of cisatracurium during intubation. [2009.01]

Priming with rocuronium or vecuronium prevents remifentanil-mediated muscle rigidity and difficult ventilation. [2009]

Pretreatment of rocuronium reduces the frequency and severity of etomidate-induced myoclonus. [2008.12]

Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine. [2008.11]

Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. [2008.08]

Significance of the injection timing of ephedrine to reduce the onset time of rocuronium. [2008.08]

Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium. [2008.07]

Rocuronium-induced withdrawal movements associated with different Rocuronium injection method. [2008.06]

Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. [2008.05]

A comparative study between one and two effective doses (ED95) of rocuronium for tracheal intubation. [2008.05]

Remifentanil prevents withdrawal movements caused by intravenous injection of rocuronium. [2008.04.30]

[Effect of ephedrine on the intubation conditions using rocuronium versus succinylcholine] [2008.04]

Quantitation of the effect of nitrous oxide on rocuronium infusion requirements using closed-loop feedback control. [2008.03]

Neutralized rocuronium (pH 7.4) before administration prevents injection pain in awake patients: a randomized prospective trial. [2007.09]

Esmolol pretreatment reduces the frequency and severity of pain on injection of rocuronium. [2007.09]

Rapid sequence induction and intubation with 1 mg/kg rocuronium bromide in cesarean section, comparison with suxamethonium. [2007.09]

[Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial] [2007.08]

Priming with rocuronium accelerates neuromuscular block in children: a prospective randomized study. [2007.07]

A comparison of intubation conditions and time-course of action with rocuronium and mivacurium for day case anaesthesia. [2007.06]

Does dexmedetomidine reduce the injection pain due to propofol and rocuronium? [2007.06]

Observations on the muscle relaxant rocuronium bromide in the horse--a dose-response study. [2007.03]

Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. [2007.03]

Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. [2007.03]

A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. [2007.03]

Pretreatment with remifentanil to prevent withdrawal after rocuronium in children. [2007.01]

The effects of ketamine and rocuronium on the A-Line auditory evoked potential index, Bispectral Index, and spectral entropy monitor during steady state propofol and remifentanil anesthesia. [2006.12]

Do we need inhaled anaesthetics to blunt arousal, haemodynamic responses to intubation after i.v. induction with propofol, remifentanil, rocuronium? [2006.12]

Effect of an intubation dose of rocuronium on Spectral Entropy and Bispectral Index responses to laryngoscopy during propofol anaesthesia. [2006.12]

[Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients] [2006.09]

[Effects of sevoflurane and propofol on neuromuscular blocking action of Org 9426 (rocuronium bromide) infused continuously in Japanese patients] [2006.08]

Prevention of withdrawal associated with the injection of rocuronium in adults and children. [2006.08]

Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children. [2006.07]

[Randomized, multicenter study of interaction between Org 9426 (rocuronium bromide) and anesthetic agents in Japanese population] [2006.07]

[Neuromuscular blocking effects, pharmacokinetics and safety of Org 9426 (rocuronium bromide) in Japanese patients] [2006.04]

Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. [2006.04]

Rocuronium is not associated with more vocal cord injuries than succinylcholine after rapid-sequence induction: a randomized, prospective, controlled trial. [2006.03]

Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. [2006.01]

The effect of pretreatment with thiopental on reducing pain induced by rocuronium injection. [2005.12.31]

Similar preoperative hemodynamic response to pancuronium and rocuronium in high-risk cardiac surgical patients. [2005.12]

Rocuronium versus succinylcholine for rapid sequence induction of anesthesia and endotracheal intubation: a prospective, randomized trial in emergent cases. [2005.11]

Intubation conditions after rocuronium or succinylcholine for rapid sequence induction with alfentanil and propofol in the emergency patient. [2005.10]

First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. [2005.10]

Dose requirements of continuous infusion of rocuronium and atracurium throughout orthotopic liver transplantation in humans. [2005.09]

[Influence of gender on the intubation conditions with rocuronium] [2005.09]

Intubation conditions following rocuronium: influence of induction agent and priming. [2005.08]

Use of low-dose rocuronium for intubation of children during volunteer surgery abroad. [2005.08]

Effects of ephedrine on intubating conditions following priming with rocuronium. [2005.07]

The intubating laryngeal mask airway: rocuronium improves endotracheal intubating conditions and success rate. [2005.05]

The effect of nitrous oxide on the dose-response relationship of rocuronium. [2005.05]

Comparative study of intubating conditions at the first minute with suxamethonium, rocuronium and different priming techniques of rocuronium. [2005.04]

Preventing the withdrawal response associated with rocuronium injection: a comparison of fentanyl with lidocaine. [2005.04]

Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function. [2005.02]

The hemodynamic effects of ephedrine on the onset time of rocuronium in pigs. [2004.12]

Rocuronium attenuates oculocardiac reflex during squint surgery in children anesthetized with halothane and nitrous oxide. [2004.11]

Women report more pain on injection of a precurarization dose of rocuronium: a randomized, prospective, placebo-controlled trial. [2004.11]

Xenon does not prolong neuromuscular block of rocuronium. [2004.11]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017